glp-1 drugs key developments 2025 Market Trends and Global Forecasts Report 2025: A How Employers Can Manage GLP-1
Description
The gut microbiota in the cecum and feces are similar, but not necessarily the same
Patients with history of pancreatitis should use these peptides cautiously if at all
The American pharma company looks intent on closing the gap with Novo Nordisk and Eli Lilly, both of which have been dominating the global GLP-1 market for a while now
Victoza (the diabetes formulation) typically has better coverage
It has been available in Canada by prescription since 1999
Christensen M, Knop FK, Holst JJ, Vilsboll T
